drugset / Trial / NCT03931590
A Human AME Study for Omaveloxolone
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the pharmacokinetics (PK), mass balance, metabolite profiles, and rates and routes of elimination of \[14C\] omaveloxolone and derived metabolites following administration as a single 150 mg (containing approximately 90 µCi) dose to healthy male subjects.
Timeline
- Start
- 2019-04-11
- Primary completion
- 2019-05-31
- Completion
- 2019-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omaveloxolone | Small molecule | 150 mg | Oral |
Indications
No indication recorded.